David Geffen School of Medicine at UCLA is a clinical research site located in Los Angeles, California, United States 90095.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
David Geffen School of Medicine at UCLA has participated in 108 clinical trials with 25 currently active.
Therapeutic areas: Idiopathic Pulmonary Fibrosis, Mucocutaneous Lymph Node Syndrome, Renal Transplantation.
Sponsors: Galapagos NV, University of California, San Diego, Novartis Pharmaceuticals.
Trust Score: 89/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
David Geffen School of Medicine at UCLA has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
David Geffen School of Medicine at UCLA has 108 clinical trials on record, with 25 currently active. Their work covers Idiopathic Pulmonary Fibrosis, Mucocutaneous Lymph Node Syndrome, Renal Transplantation.
Yes — David Geffen School of Medicine at UCLA holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.